amlodipine has been researched along with felodipine in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.39) | 18.7374 |
| 1990's | 33 (45.83) | 18.2507 |
| 2000's | 24 (33.33) | 29.6817 |
| 2010's | 12 (16.67) | 24.3611 |
| 2020's | 2 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Alker, D; Campbell, SF; Cross, PE | 1 |
| Alker, D; Burges, RA; Campbell, SF; Carter, AJ; Cross, PE; Gardiner, DG | 1 |
| Arrowsmith, JE; Blackburn, KJ; Burges, RA; Campbell, SF; Cross, PE; Gardiner, DG; Stubbs, JK | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Beaumont, K; Smith, DA; van De Waterbeemd, H; Walker, DK | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Sun, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cheng, TO | 1 |
| Cheng, CP; Little, WC | 1 |
| Abrahamsson, T; Akerblom, B; Nordlander, M; Thalén, P | 1 |
| Kvist, S; Mulvany, MJ; Videbaek, LM | 1 |
| Høegholm, A; Nielsen, PE; Rasmussen, E; Wiinberg, N | 2 |
| Huttunen, KR; Knuuttila, ML; Pernu, HE; Tiilikainen, AS | 1 |
| Bainbridge, AD; Elliott, HL; Herlihy, O; Meredith, PA | 1 |
| Cheng, CP; Little, WC; Noda, T; Nordlander, M; Ohno, M | 1 |
| Lund-Johansen, P; Omvik, P | 1 |
| Goldsmith, SR | 1 |
| Cheng, CP; Elvelin, L; Little, WC; Nordlander, M | 1 |
| Block, LH; Nauck, M; Rödler, S; Roth, M; Tamm, M | 1 |
| Block, LH; Eickelberg, O; Erne, P; Kohler, E; Roth, M | 1 |
| Matesić, D; Mrsić, J; Simonić, A; Vitezić, D; Zupan, G | 1 |
| Lewis, BS | 1 |
| Höher, M; Koenig, W | 1 |
| Elliott, HL; Meredith, PA | 1 |
| Alpers, JA; Bune, AJ; Frith, PA; McEvoy, RD; Sajkov, D; Wang, T | 1 |
| White, CM | 1 |
| Jacobsen, IA; Videbaek, LM | 1 |
| Archambault, F; Jewell, D; Lacourcière, Y; Lefebvre, J; Poirier, L; Reed, CV | 1 |
| Brodin, U; Isaksson, H; Ohman, KP; Ostergren, J; Schwan, A | 1 |
| Seibold, JR; Sturgill, MG | 1 |
| Aldons, PM; Burgess, ED; Girerd, X; Morgan, TO; Rehn, L; Schaefer, RM; Singh, GP; Tilvis, R | 1 |
| Chen, H; Daloze, P; Dumont, L; Lapointe, N; Qi, S; Xu, D | 1 |
| Boivin, JM; Zannad, F | 1 |
| Ellsworth, A; Fink, KS | 1 |
| Laufen, H; Riedel, KD; Scharpf, F; Schumacher, T; Yeates, R; Zimmermann, T | 1 |
| Anguita Sánchez, M | 1 |
| de Vries, RJ; Dunselman, PH; van Veldhuisen, DJ | 1 |
| Nakamoto, H; Okada, H; Shouda, J; Sugahara, S; Suzuki, H | 1 |
| Bourg, MP; Clay, DR; Lawrence, DB | 1 |
| Beckey, NP; Korman, L; Parra, D | 1 |
| LeLorier, J; Sheehy, O | 1 |
| Arbus, GS; Blowey, D; Khattak, S; Koren, G; Lyszkiewicz, DA; Rogan, JW | 1 |
| Corradi, L; Fogari, R; Malalamani, GD; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Williams, CD | 1 |
| Isaksson, H; Nyström, FH; Ohman, KP; Ostergren, J; Schwan, A | 1 |
| Faulkner, M; Hilleman, DE; Reyes, AP; Wurdeman, RL | 1 |
| Florea, S; Raicu, M | 1 |
| Basavaiah, K; Chandrashekar, U; Prameela, HC | 1 |
| Annis, LG; Blivin, SJ; Lyons, F; Pippins, J | 1 |
| Manzo, BA; Matalka, MS; Ravnan, SL | 1 |
| Coletta, E; Leenen, FH; White, R | 1 |
| Bremer, T; Diamond, C; Kask, K; Man, A | 1 |
| Borbas, E; Handrock, R; Klebs, S; Schaetzl, R; Trenkwalder, P | 1 |
| Coletta, E; Leenen, FH | 1 |
| Baron, JA; Bøtker, HE; Jensen, LO; Johansen, MB; Kaltoft, A; Maeng, M; Robertson, DJ; Schmidt, M; Sørensen, HT; Tilsted, HH | 1 |
| Chen, W; Fang, H; Liu, X; Xu, W | 1 |
| Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH | 1 |
| Abreu-Villela, R; Adler, C; Caraballo, I; Kuentz, M | 1 |
| de Souza, RC; Ferreira, DC; Fischer, RG; Gonçalves, LS; Vidal, F | 1 |
| Abbas, N; Akhtar, F; Bukhari, NI; Gilani, SAN; Javed, A; Kanwal, U; Shamim, R | 1 |
| Tchernev, G | 1 |
7 review(s) available for amlodipine and felodipine
| Article | Year |
|---|---|
Property-based design: optimization of drug absorption and pharmacokinetics.
Topics: Animals; Biological Transport; Blood Proteins; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane; Drug Design; Eye; Humans; Intestinal Absorption; Models, Biological; Models, Molecular; Nasal Mucosa; Pharmaceutical Preparations; Pharmacokinetics; Prodrugs; Skin Absorption | 2001 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Vascular versus myocardial effects of calcium antagonists.
Topics: Amlodipine; Animals; Dogs; Felodipine; Heart Failure; Hemodynamics; Humans; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Pressoreceptors; Ventricular Function, Left | 1994 |
Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.
Topics: Amlodipine; Calcium Channel Blockers; Coronary Disease; Felodipine; Heart Failure; Hemodynamics; Humans; Hypertension; Myocardial Contraction; Nifedipine; Vasodilation | 1995 |
Calcium antagonists in patients with left ventricular dysfunction: back on the bridge?
Topics: Amlodipine; Calcium Channel Blockers; Felodipine; Humans; Myocardial Infarction; Ventricular Dysfunction, Left | 1996 |
Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Felodipine; Heart Failure; Humans; Nicardipine; Nifedipine; Ventricular Dysfunction, Left; Verapamil | 1997 |
Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
Topics: Amlodipine; Calcium Channel Blockers; Dihydropyridines; Exercise Test; Exercise Tolerance; Felodipine; Heart Failure; Hemodynamics; Humans; Ventricular Function, Left | 2000 |
21 trial(s) available for amlodipine and felodipine
| Article | Year |
|---|---|
Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group.
Topics: Adult; Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Felodipine; Female; Humans; Hypertension; Male; Middle Aged | 1995 |
A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices.
Topics: Aged; Amlodipine; Blood Pressure; Delayed-Action Preparations; Felodipine; Female; Heart Rate; Humans; Male; Middle Aged | 1993 |
Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. Danish Multicentre Group.
Topics: Adult; Aged; Amlodipine; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Delayed-Action Preparations; Diastole; Double-Blind Method; Drug Administration Schedule; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Office Visits; Systole; Treatment Outcome | 1995 |
Effect of amlodipine and felodipine on sympathetic activity and baroreflex function in normal humans.
Topics: Adult; Amlodipine; Analysis of Variance; Baroreflex; Calcium Channel Blockers; Double-Blind Method; Felodipine; Head-Down Tilt; Hemodynamics; Humans; Male; Norepinephrine; Sympathetic Nervous System | 1995 |
Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Electrocardiography, Ambulatory; Felodipine; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Treatment Outcome | 1997 |
Amlodipine--does the effect-time profile directly reflect the concentration-time profile throughout a 24-hour period?
Topics: Aged; Amlodipine; Double-Blind Method; Felodipine; Female; Humans; Male; Middle Aged; Time Factors | 1994 |
A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Felodipine; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Patient Selection; Single-Blind Method; Vasodilator Agents | 1997 |
Crossover comparison of the pharmacokinetics of amlodipine and felodipine ER in hypertensive patients.
Topics: Adult; Amlodipine; Antihypertensive Agents; Area Under Curve; Blood Pressure; Cross-Over Studies; Delayed-Action Preparations; Felodipine; Female; Half-Life; Humans; Hypertension; Male; Middle Aged | 1997 |
Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Topics: Adult; Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Delayed-Action Preparations; Felodipine; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Outpatients; Treatment Outcome | 1998 |
Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Felodipine; Female; Humans; Hypertension; Male; Middle Aged | 1998 |
Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study Group.
Topics: Aged; Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dizziness; Double-Blind Method; Edema; Felodipine; Female; Headache; Humans; Hypertension; Male | 1998 |
Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged | 1999 |
The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times.
Topics: Adult; Amlodipine; Area Under Curve; Biological Availability; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Diltiazem; Felodipine; Female; Gastrointestinal Diseases; Gastrointestinal Transit; Headache; Humans; Male; Middle Aged; Time Factors | 1999 |
Patterns of amlodipine and felodipine use in an elderly Quebec population.
Topics: Aged; Amlodipine; Antihypertensive Agents; Felodipine; Female; Humans; Hypertension; Male; Patient Compliance; Quebec | 2000 |
A randomized prospective crossover trial of amlodipine in pediatric hypertension.
Topics: Adolescent; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Child; Cross-Over Studies; Felodipine; Female; Humans; Hypertension; Male; Nifedipine; Patient Compliance; Prospective Studies | 2000 |
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Norepinephrine; Piperazines; Sympathetic Nervous System | 2000 |
Less difference between office and ambulatory blood pressure in women than in men both before and during antihypertensive treatment.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Office Visits; Sex Factors; Single-Blind Method | 2000 |
Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiovascular Physiological Phenomena; Creatinine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Renin; Sympathetic Nervous System | 2006 |
Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Resistance; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Pharmacokinetic and antihypertensive profile of amlodipine and felodipine-ER in younger versus older patients with hypertension.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Young Adult | 2010 |
The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Asian People; Blood Pressure; Calcium Channel Blockers; China; Circadian Rhythm; Drug Therapy, Combination; Essential Hypertension; Felodipine; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Nifedipine; Propanolamines; Treatment Outcome | 2014 |
44 other study(ies) available for amlodipine and felodipine
| Article | Year |
|---|---|
Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy)methyl]-5 -(methoxycarbonyl)-6-methyl-1,4-dihydropyridine.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Dogs; Heart Rate; Indicators and Reagents; Magnetic Resonance Spectroscopy; Molecular Structure; Structure-Activity Relationship | 1991 |
Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Chemical Phenomena; Chemistry; Dihydropyridines; Dogs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Nicotinic; Structure-Activity Relationship; Time Factors; Vasodilator Agents | 1990 |
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.
Topics: Amlodipine; Animals; Biological Assay; Biological Availability; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihydropyridines; Dogs; Guinea Pigs; Hemodynamics; Kinetics; Male; Nifedipine; Pyridines; Rats; Vasoconstriction | 1986 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
All calcium channel blockers are not alike.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Heart Failure; Humans; Nifedipine | 1991 |
Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Felodipine; Heart; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nifedipine; Organ Specificity; Rats; Rats, Inbred SHR | 1995 |
Time course of action of amlodipine and felodipine in the rat is most rapid in small arteries.
Topics: Amlodipine; Analysis of Variance; Animals; Aorta; Calcium; Calcium Channel Blockers; Felodipine; Linear Models; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium; Rats; Rats, Wistar; Software; Time Factors; Vascular Resistance | 1995 |
Drug-induced gingival overgrowth and class II major histocompatibility antigens.
Topics: Adult; Amlodipine; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Felodipine; Female; Gingiva; Gingival Diseases; Histocompatibility Testing; HLA-DR Antigens; Humans; Kidney Transplantation; Male; Nifedipine; Retrospective Studies; Risk Factors | 1994 |
Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Dogs; Felodipine; Heart; Heart Rate; Heart Ventricles; Hemodynamics; Myocardial Contraction; Nifedipine | 1994 |
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines | 1993 |
Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells.
Topics: Adrenergic beta-Antagonists; Amlodipine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Dihydropyridines; Diuretics; Felodipine; Fibroblasts; Furosemide; Gene Expression Regulation; Humans; Interleukin-6; Interleukin-8; Isradipine; Lung; Muscle Proteins; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Propranolol; Transcription, Genetic | 1995 |
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix.
Topics: Amlodipine; Becaplermin; Calcium Channel Blockers; Cells, Cultured; Collagen; Collagenases; Dihydropyridines; Diltiazem; Enzyme Activation; Extracellular Matrix; Felodipine; Fibroblasts; Humans; Kinetics; Lung; Metalloendopeptidases; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Platelet-Derived Growth Factor; Procollagen; Proline; Proto-Oncogene Proteins c-sis; Transcription, Genetic; Verapamil | 1996 |
Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat.
Topics: Amlodipine; Amnesia; Animals; Calcium Channel Blockers; Electroconvulsive Therapy; Felodipine; Nimodipine; Rats; Rats, Wistar | 1996 |
Rational use of calcium-channel antagonists in Raynaud's phenomenon.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Humans; Isradipine; Nicardipine; Nifedipine; Raynaud Disease | 1998 |
Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
Topics: Adjuvants, Immunologic; Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Felodipine; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mibefradil; Rats; Rats, Inbred Lew; Tetrahydronaphthalenes; Time Factors | 1999 |
Antihypertensive treatment and CHD in the elderly.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Double-Blind Method; Felodipine; Fosinopril; Humans; Hypertension; Myocardial Infarction; Nisoldipine; Nitrendipine; Randomized Controlled Trials as Topic | 1999 |
[Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Carbazoles; Carvedilol; Clinical Trials as Topic; Databases, Bibliographic; Felodipine; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Meta-Analysis as Topic; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Systole; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
Incidence of gingival hyperplasia caused by calcium antagonists in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Amlodipine; Calcium Channel Blockers; Cardiovascular Diseases; Felodipine; Female; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Peritoneal Dialysis, Continuous Ambulatory | 1999 |
Outcomes of an amlodipine-to-felodipine therapeutic interchange program.
Topics: Aged; Amlodipine; Antihypertensive Agents; Chi-Square Distribution; Confidence Intervals; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Program Evaluation; Retrospective Studies; Therapeutic Equivalency; Treatment Outcome | 2000 |
Retrospective evaluation of the conversion of amlodipine to alternative calcium channel blockers.
Topics: Amlodipine; Blood Pressure; Calcium Channel Blockers; Diltiazem; Felodipine; Female; Humans; Hypertension; Male; Nifedipine; Retrospective Studies | 2000 |
Costs and outcomes of switching from amlodipine to felodipine.
Topics: Amlodipine; Calcium Channel Blockers; Cardiovascular Diseases; Felodipine; Humans; Treatment Outcome | 2000 |
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Costs and Cost Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Treatment Outcome | 2001 |
Deleterious effects of nifedipine on smooth muscle cells implies alterations of intracellular calcium signaling.
Topics: Amlodipine; Aorta; Caffeine; Calcium; Calcium Channel Blockers; Calcium Signaling; Calcium-Transporting ATPases; Cells, Cultured; Endoplasmic Reticulum; Enzyme Inhibitors; Felodipine; Genistein; Humans; Muscle, Smooth, Vascular; Nifedipine; Protein-Tyrosine Kinases; Thapsigargin | 2001 |
Dihydropyridines are not substitutable without careful monitoring.
Topics: Adverse Drug Reaction Reporting Systems; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Delayed-Action Preparations; Dihydropyridines; Felodipine; Humans; Nifedipine | 2002 |
Sensitive spectrophotometric determination of amlodipine and felodipine using iron(III) and ferricyanide.
Topics: Amlodipine; Felodipine; Ferric Compounds; Ferricyanides; Spectrophotometry | 2003 |
A comparative analysis of amlodipine and felodipine in a military outpatient population: efficacy, outcomes, and cost considerations.
Topics: Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cost Control; Drug Costs; Felodipine; Female; Florida; Hospitals, Military; Humans; Hypertension; Male; Medical Audit; Middle Aged; Military Personnel; Naval Medicine; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2003 |
Evaluation of a therapeutic conversion from amlodipine to felodipine.
Topics: Aged; Amlodipine; Blood Pressure; Data Collection; Drug Evaluation; Felodipine; Heart Rate; Humans; Hypertension; Male; Middle Aged; Patient Satisfaction; Retrospective Studies | 2003 |
CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Felodipine; Female; Genotype; Haplotypes; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Retrospective Studies | 2006 |
Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiovascular Diseases; Child; Child, Preschool; Clopidogrel; Cohort Studies; Denmark; Drug Interactions; Felodipine; Female; Humans; Infant; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Stents; Ticlopidine; Verapamil; Young Adult | 2012 |
Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Stroke; Taiwan; Young Adult | 2017 |
Electron microscopy/energy dispersive X-ray spectroscopy of drug distribution in solid dispersions and interpretation by multifractal geometry.
Topics: Amlodipine; Crystallography, X-Ray; Dosage Forms; Drug Carriers; Drug Compounding; Felodipine; Fractals; Glyburide; Indomethacin; Methylcellulose; Microscopy, Electron, Scanning; Pharmaceutical Preparations; Powder Diffraction; Solubility; Spectrometry, X-Ray Emission; Technology, Pharmaceutical | 2018 |
Influence of 3 calcium channel blockers on gingival overgrowth in a population of severe refractory hypertensive patients.
Topics: Adult; Aged; Amlodipine; Brazil; Calcium Channel Blockers; Felodipine; Female; Gingival Overgrowth; Humans; Hypertension; Male; Middle Aged; Nifedipine; Periodontal Index | 2018 |
Development of Simple Dissolution Methods for Felodipine and Combined Amlodipine Besylate-Indapamide Extended Release Tablets without Stationary (Felodipine) Basket.
Topics: Amlodipine; Felodipine; Humans; Indapamide; Solubility; Tablets | 2022 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |